...
首页> 外文期刊>Journal of International Medical Research >Human Telomerase Gene Amplification and High-Risk Human Papillomavirus Infection in Women with Cervical Intra-Epithelial Neoplasia
【24h】

Human Telomerase Gene Amplification and High-Risk Human Papillomavirus Infection in Women with Cervical Intra-Epithelial Neoplasia

机译:宫颈上皮内瘤变妇女的人类端粒酶基因扩增和高危人类乳头瘤病毒感染。

获取原文
           

摘要

This study was designed to investigate whether a correlation exists between amplification of the human telomerase gene (human telomerase RNA component [TERC]) and high-risk human papillomavirus (HR-HPV) infection in 101 women with cervical intra-epithelial neoplasia (CIN). Eight patients (7.9%) had CIN 1, 24 (23.8%) had CIN 2 and 69 (68.3%) had CIN 3. TERC was amplified in 31.7% of all CIN patients. The difference in frequency of TERC amplification between patients with low-grade CIN (CIN 1) and those with high-grade CIN (CIN 2 and CIN 3) was not significant. HR-HPV infection was detected in 88.1% of all CIN cases and was significantly more frequent in patients with CIN 2 and CIN 3 than in patients with CIN 1. There was no significant difference in the frequency of HR-HPV infection between groups of patients with and without TERC amplification. In conclusion, this study found no correlation between TERC amplification and HR-HPV infection in patients with CIN.
机译:这项研究旨在调查101例宫颈上皮内瘤变(CIN)妇女的人类端粒酶基因(人类端粒酶RNA组分[TERC])扩增与高危人类乳头瘤病毒(HR-HPV)感染之间是否存在相关性。 。 8例(7.9%)的CIN 1患者,24例(23.8%)的CIN 2和69例(68.3%)的CIN 3在所有CIN患者中31.7%的TERC得以扩增。低度CIN(CIN 1)和高度CIN(CIN 2和CIN 3)患者之间的TERC扩增频率差异不显着。在所有CIN病例中,HR-HPV感染的检出率为88.1%,在CIN 2和CIN 3的患者中明显高于CIN 1的患者。两组之间的HR-HPV感染频率无明显差异有和没有TERC放大。总之,这项研究发现CIN患者的TERC扩增与HR-HPV感染之间没有相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号